id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3596-0001,FDA,FDA-2018-N-3596,Medical Devices; Immunology and Microbiology Devices; Classification of the Herpes Virus Nucleic Acid-Based Cutaneous and Mucocutaneous Lesion Panel,Rule,Final Rule,2018-10-17T04:00:00Z,2018,10,2018-10-17T04:00:00Z,,2018-10-17T13:42:38Z,2018-22694,0,0,09000064837fd166